Globally, only 15% of cancer cases are detected at an early stage.
CortexAI, developed by a team of students and alumni from AITU, introduces a next-generation approach to clinical diagnostics.
The system functions as a multimodal AI agent, capable of analyzing CT, MRI, PET scans, symptoms, lab reports, and patient history. It offers detailed insights, interprets findings, and supports clinical decision-making through state-of-the-art machine learning models.
75.1% accuracy on lung cancer X-ray detection in simulation
Powered by ResNet18, MobileNetV1, and trained on Luna16 and Kaggle datasets
Reviewed by professionals affiliated with Harvard, Duke
Prepared for integration into 30+ clinics across Kazakhstan and beyond
Winner of the Enactus National Expo Early Stage Competition
Representing Kazakhstan at the Enactus World Cup 2025 in Bangkok, Thailand
AITU is shaping a new generation of engineers and scientists capable of addressing global health challenges.
CortexAI exemplifies this mission — bridging academic research with real clinical impact.